Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crysvita in children 1-4 years old with XLH
NCT02750618Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- May 2016
- Primary completion
- Apr 2017
- Countries
- 1
01
Overview
A Phase 2 trial of burosumab in X-linked hypophosphatemia (XLH), sponsored by Kyowa Kirin. Started May 2016; status: completed.
02
Drugs
burosumab
03
Conditions
X-linked hypophosphatemia (XLH)
Beyond the preview
Go deeper on NCT02750618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02750618.